Leishmania and SHP-1: How a Parasite Inactivates a Key Immune Kinase
Author Information
Author(s): Abu-Dayyeh Issa, Shio Marina Tiemi, Sato Shintaro, Akira Shizuo, Cousineau Benoit, Olivier Martin
Primary Institution: McGill University
Hypothesis
Leishmania could exploit SHP-1 to inactivate key kinases involved in Toll-like receptor (TLR) signalling and innate immunity such as IL-1 receptor-associated kinase 1 (IRAK-1).
Conclusion
Leishmania can rapidly inactivate IRAK-1 kinase activity through the binding of SHP-1 to an evolutionarily conserved KTIM motif, leading to the inhibition of macrophage functions.
Supporting Evidence
- Leishmania infection leads to a significant inhibition of LPS-mediated IL-12 expression, TNF production, and NO generation in macrophages.
- SHP-1 deficiency in macrophages results in increased IRAK-1 activity and enhanced inflammatory responses.
- IRAK-1 is shown to be tyrosine phosphorylated, indicating its active role in signaling pathways.
- The KTIM motif in IRAK-1 is evolutionarily conserved and plays a critical role in its regulation by SHP-1.
Takeaway
Leishmania, a type of parasite, can trick our immune system by using a special protein to turn off a key part of our body's defense, making it harder for us to fight the infection.
Methodology
The study involved in vitro experiments using macrophages infected with Leishmania and various assays to measure IRAK-1 activity and SHP-1 interaction.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website